Home Other Building Blocks 2-METHYLBENZANILIDE

2-METHYLBENZANILIDE

CAS No.:
7055-03-0
Catalog Number:
AG00FAQ3
Molecular Formula:
Molecular Weight:
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
250mg
98%
1 week
United States
$142
- +
Product Description
Catalog Number:
AG00FAQ3
Chemical Name:
2-METHYLBENZANILIDE
CAS Number:
7055-03-0
MDL Number:
MFCD00017210
IUPAC Name:
2-methyl-N-phenylbenzamide
InChI:
InChI=1S/C14H13NO/c1-11-7-5-6-10-13(11)14(16)15-12-8-3-2-4-9-12/h2-10H,1H3,(H,15,16)
InChI Key:
MZNCVTCEYXDDIS-UHFFFAOYSA-N
EC Number:
230-334-4
UNII:
B8MA40FMWG
Properties
Complexity:
233  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
211.1g/mol
Formal Charge:
0
Heavy Atom Count:
16  
Hydrogen Bond Acceptor Count:
1  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
211.264g/mol
Monoisotopic Mass:
211.1g/mol
Rotatable Bond Count:
2  
Topological Polar Surface Area:
29.1A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
2.9  
Literature
Title Journal
Conformation study of 2-arylbenzimidazoles as inhibitors of Chlamydia pneumoniae growth. Bioorganic & medicinal chemistry letters 20120715
N-(4-Chloro-phen-yl)-2-methyl-benzamide. Acta crystallographica. Section E, Structure reports online 20090201
N-(2-Chloro-phen-yl)-2-methyl-benzamide. Acta crystallographica. Section E, Structure reports online 20080801
3-Methyl-N-phen-ylbenzamide. Acta crystallographica. Section E, Structure reports online 20080401
2-Methyl-N-phenyl-benzamide. Acta crystallographica. Section E, Structure reports online 20080201
2-Methyl-N-(3-methyl-phen-yl)benzamide. Acta crystallographica. Section E, Structure reports online 20080201
Microsphere-based protease assays and screening application for lethal factor and factor Xa. Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Synthesis of 17beta-N-substituted 19-Nor-10-azasteroids as inhibitors of human 5alpha-reductases I and II. Bioorganic & medicinal chemistry 20021101
Properties